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ABSTRACT 
Immune cells need fine-tuned intercellular communication to properly respond to 
pathogens. Recently, researchers characterized a novel form of intercellular 
communication where microRNAs (miRNAs) can be transferred between cells in 
exosomes. Immune miRNAs, such as miR-155 and miR-146a, are important for post-
transcriptional gene regulation and are essential for proper immune cell function. miR-155 
is proinflammatory while miR-146a is an anti-inflammatory miRNA. We found that miR-
155 and miR-146a were released from bone marrow derived dendritic cells (BMDCs) 
within exosomes and are transferred to recipient BMDCs. Upon transfer, miRNAs 
decreased levels of their mRNA targets in recipient cells in a seed dependent manner and 
reprogrammed the cellular response to endotoxin. Exosomal miR-155 enhanced, 
whilemiR-146a reduced, inflammatory gene expression. Additionally, injection of miR-
146a containing exosomes into mice delivered miR-146a to various tissues and decreased 
inflammation in response to endotoxin, while miR-155 containing exosomes had the 
converse effect. Using the Rab27ab-/- (Rab27DKO) mice, which are deficient in producing 
exosomes, we assayed the importance of exosomes during endotoxin response in vivo and 
observed that these mice have defective response to endotoxin, which could be rescued 
with injection of WT exosomes. These results suggest that exosome uptake is important 
for proper response to endotoxin. We are continuing to utilize the Rab27DKO model to 
investigate the role of exosomes during normal hematopoietic development and during 
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various disease states. We have found that Rab27DKO mice have a slight resting 
myeloproliferative disorder as well as over-activated T cells. Their extrameduallary 
hematopoiesis defects can be rescued by the presence of WT bone marrow (BM) and by 
injection of WT exosomes in resting mice suggesting that exosome uptake is important for 
this phenotype. Additionally, in a multiple sclerosis (MS) model, Experimental 
Autoimmune Encephalomyelitis (EAE), Rab27DKO mice have worsened disease, which 
we hypothesize is due to their increase in activated T cells at rest. Overall, our results 
suggest that exosomal communication is important for normal hematopoietic development 
and is involved in immune responses to challenge.  
To my family, 
Donald Griffith, Constance Griffith, Pamela Griffith, James Alexander, Nancy 
Alexander, Rebecca Alexander, Katherine Alexander, and Kevin Hallman 
TABLE OF CONTENTS 
ABSTRACT ....................................................................................................................... iii 
LIST OF TABLES ........................................................................................................... viii 
LIST OF FIGURES ........................................................................................................... ix 
ACKNOWLEDGEMENTS ..............................................................................................xiii 
Chapters 
1. INTRODUCTION .........................................................................................................1 
Discovery and characteristics of exosomes .............................................................2 
References ................................................................................................................7 
2. NONCODING RNAS AND CHRONIC INFLAMMATION: MICROMANAGING
THE FIRE WITHIN.....................................................................................................10 
Abstract ..................................................................................................................11     
Introduction ............................................................................................................12 
Causes of chronic inflammation ............................................................................13 
The regulatory potential of noncoding RNAs in the immune system ...................15 
MicoRNAs, immune responses, and the regulation of cellular physiology  .........15 
Functional role for miRNAs during chronic inflammation ...................................16 
MicroRNAs are emerging biomarkers and therapeutic targets in chronic 
inflammation ..........................................................................................................17 
Long non-coding RNAs are involved in chronic inflammation ............................19 
Conclusions and outlook ........................................................................................19 
References ..............................................................................................................19 
3. EXOSOME-DELIVERED MICRORNAS MODULATE THE INFLAMMATORY









Author contributions ..............................................................................................38 
Additional information ...........................................................................................38 
4. RAB27-DEPENDENT EXOSOME PRODUCTION INHIBITS CHRONIC
INFLAMMATION AND ENABLES ACUTE RESPONSES TO INFLAMMATORY
     STIMULI......................................................................................................................39 




Materials and methods ...........................................................................................64 
Acknowledgements ................................................................................................68 
References ..............................................................................................................68 
5. IMPORTANCE OF EXOSOMAL COMMUNICATION IN T CELL ACTIVATION





Materials and methods ...........................................................................................84 
Acknowledgements ................................................................................................85 
References ..............................................................................................................86 
6.   DISCUSSION ..............................................................................................................88 
Existing state of the exosomal miRNA communication field ...............................89 
New insights into the roles of exosomal transfer of miRNAs and the roles of 
exosomes during intercellular communication ......................................................91 
Future directions in the exosomal communication field  .......................................92 
Implications of the exosome mediated transfer of miRNAs ..................................94 
References ..............................................................................................................94 
Discussion ..............................................................................................................32 
LIST OF TABLES 
2.1. Selected examples of ncRNAs with roles in regulating inflammation.....................15 
LIST OF FIGURES 
Figures 
2.1 Mechanisms, anatomical locations and disease types involving chronic 
inflammation.............................................................................................................13 
2.2 Mechanisms of miRNA function in the immune system..........................................16 
2.3 Sequential threshold model of age-dependent diseases linked to miRNA regulated 
chronic inflammation................................................................................................17 
3.1 miR-155 is transferred between BMDCs and is present in exosomes......................25 
3.2 Functional transfer of miR-155 via exosomes in vitro.............................................26 
3.3 Functional transfer of miR-146a via exosomes in vitro............................................28 
3.4 Seed-dependent repression of miRNA targets by exosome delivered miR-155 and 
miR-146a..................................................................................................................30
3.5 Exosomal transfer of miR-155 and miR-146a programme the response to LPS in
vitro...........................................................................................................................31 
3.6 Transfer of endogenous miR-155 between hematopoietic cells in vivo...................32 
3.7 miR-155-containing exosomes promote a heightened response to LPS in miR-155 -
/- mice.......................................................................................................................33 
3.8 miR-146a-conatining exosomes reduce inflammatory responses to LPS in miR-146a
-/- mice......................................................................................................................34 
3.9 miR-146a-containing exosomes reduce inflammatory response in Wt mice............35 
4.1 Rab27DKO mice display chronic, low-grade inflammation....................................45 
4.2 Certain Rab27DKO phenotypes are cell extrinsic....................................................47 
4.3 WT exosome treatment can complement certain Rab27DKO phenotypes..............50 
4.4 Rab27DKO mice have a refractory response to LPS................................................53 
4.5 Injection of WT exosomes restores responsiveness to LPS by Rab27DKO mice....55 
4.6 Restoration of LPS responsiveness by Rab27DKO mice is dependent on miR-
155............................................................................................................................58 
4.7 Model of the role of exosomal miR-155 in LPS response........................................62 
5.1 Rab27DKO mice have increased activated T, TFH, and germinal center B cells....77 
5.2 Aberrant activation of Rab27DKO CD4+ T cells is a cell intrinsic defect..............79 
5.3 WT exosome injections cannot rescue aberrant T cell activation in Rab27DKO 
mice...........................................................................................................................80 
5.4 Rab27DKO mice are more susceptible to EAE........................................................82 
x
LIST OF ABBREVIATIONS 
AD..........................................................................................................Alzheimer’s disease 
BM....................................................................................................................Bone marrow 
BMDC............................................................................Bone marrow derived dendritic cell 
CVD...................................................................................................Cardiovascular disease 
DAMPs......................................................................Damage associated molecular patterns 
DC....................................................................................................................Dendritic cell 
EAE................................................................Experimental autoimmune encephalomyelitis 
EM.........................................................................................................Electron microscopy 
FACS................................................................................Florescence-activated cell sorting 
GCB..................................................................................................Germinal center B cells 
GM-BM...................................................................................GMCF cultured bone marrow 
IBD............................................................................................Inflammatory bowel disease  
i.p..........................................................................................................Immunoprecipitation
lncRNA...............................................................................................Long noncoding RNA 
LPS.........................................................................................................Lipopolysaccharide 






nSMase2.....................................................................................neutral sphingomyelinase 2 
NTA.................................................................................non-templated nucleotide addition 
qRT-PCR..................................................................Quantitative reversetranscriptase-PCR 
RA.........................................................................................................Rheumatoid arthritis 
Rab27DKO............................................................................Rab27a and b double knockout 
RISC..................................................................................RNA-induced silencing complex 
SLE. .......................................................................................Systemic lupus erythematosus 
T1D...............................................................................................................Type 1 diabetes 
T2D...............................................................................................................Type 2 diabetes 
TCR.................................................................................................................T cell receptor 
TFH.....................................................................................................T follicular helper cell 
TLR............................................................................................................Toll-like receptor 
TNF.....................................................................................................Tumor necrosis factor 




I am indebted to the fabulous mentorship I have received throughout my thesis 
research from my mentor, Dr. Ryan O’Connell. His enthusiasm and guidance has been 
essential to my success and overall enjoyment of the past years. I would also like to 
acknowledge my committee, Drs. Diane Ward, Brenda Bass, Tom Lane, and Matt Mulvey 
and the department of Pathology who have always provided invaluable feedback to my 
dissertation research. I would especially like to thank Ryan O’Connell, June Round, Matt 
Mulvey, and Brittany Fleming for indulging my crazy ideas. My lab mates have been not 
only extremely influential in their comments and suggestions of direction to go with my 
research, but also in the awesome lab environment I have had the pleasure of experiencing 
these past years. In addition, I would like to acknowledge my classmate and students in the 
Pathology department for insightful comments and overall enjoyment of my time working 
on my dissertation research. 
CHAPTER 1 
INTRODUCTION 
Discovery and characteristics of exosomes 
In 1983, the Pan and Johnstone group and the Harding, Heuser, and Stahl team 
observed that reticulocytes release vesicles containing the transferrin receptor into the 
extracellular space (1, 2). These were the first descriptions of exosomes, which Johnstone 
further characterized in 1987 as having activity associated with the plasma membrane. It 
was initially thought that these shed vesicles were merely a way cells could rid themselves 
of unwanted content. Indeed, there did not seem to be much interest in these vesicles for 
many years after their discovery and many believed that the release of exosomes seen by 
the Johnstone and Stahl labs was an artifact (3). Despite this, the Johnstone and Stahl labs 
worked to characterize how to isolate these vesicles and began to identify components 
associated with them. By utilizing electron microscopy (EM) they observed that transferrin 
localized to both the intraluminal vesicles inside the multivesicular body (MVB) within the 
cell and was also present on exosomes released from the cell (2, 4). In the EM images, the 
MVB appeared to fuse with the plasma membrane to release the exosomes into the 
extracellular space. This suggested a role for the MVB in the biogenesis of exosomes. From 
the EM images they were also able to estimate the size of exosomes to be approximately 
50nm and described the exosomes as being composed of a single lipid bilayer. Since then, 
the size of exosomes has been characterized to be in the range of 40-100nm (5).  
After these initial observations of exosomes, it has been appreciated that exosomes 
are not the only form of secreted vesicle. Several categories of larger membrane structures 
have been isolated from cells, including microvesicles that range in size from 150nm-
1000nm and apoptotic bodies that range from 1µm-5µm (5). Due to the presence of other 
secreted vesicles, the isolation of exosomes has been a topic of great discussion. 
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Classically, exosomes have been isolated via differential centrifugation, where the cell-
culture supernatant is subjected to multiple centrifugations at increasing speeds to remove 
cellular debris and larger vesicles (6). However, there is a push in the field to further isolate 
exosomes based on various markers properties (6).    
As the isolation techniques for exosomes improved, the field was able to investigate 
the molecular make-up of these vesicles. Initial investigation of exosomal content consisted 
of western blots of know cellular proteins on exosomes isolated from various cell types (7). 
Certain cell types have had more extensive characterization performed. For example, 
dendritic cell (DC) exosomal protein composition has been analyzed with mass 
spectrometry. This unbiased approach identified unexpected proteins associated with 
exosomes such as the MHC class II protein. With these approaches both ubiquitous and 
cell-specific proteins have been identified and these proteins can be contained within the 
exosomes or spanning the membrane. Many different classes of proteins were identified 
including cytoskeletal, heat shock, MHC class I and II, and tetraspanins. Tetraspanins such 
as CD63 and CD81 on exosomes have since been used as marker of exosomes.   
Exosome biogenesis, secretion, and uptake 
After the initial observation that exosomes were being secreted via the MVB, the 
biogenesis of exosomes began to be investigated further. Classically, the MVB was thought 
to fuse with the lysosome to degrade surface proteins. However, the MVB can also traffic 
to and fuse with the plasma membrane resulting in the release of exosomes into the 
extracellular space (8). SNARE proteins are involved in the fusion event between the MVB 
and plasma membrane that results in exosome release (7). Rab27a and Rab27b are two 
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GTPases that are important for the docking and retention of the MVB at the plasma 
membrane (9). The knockout of Rab27a and b dramatically reduces exosomes secretion, 
and thus makes a strong tool for studying these vesicles in vivo (9).  
Once secreted, exosomes can be taken up by other cells and deliver their content to 
the cytoplasm of the recipient cell (10). The mechanism of this uptake is still not completely 
worked out; however, there are three proposed ways to deliver exosomes (11). One theory 
contends that the membrane of exosomes can fuse to the plasma membrane to deliver its 
contents to the cytoplasm. There has been some evidence for this theory where researchers 
have observed hemi-fusion of the exosome and plasma membranses via EM (12). The 
second theory suggests that the exosome is taken up via endocytosis that could be mediated 
by clathrin or caveolin (13). Once the exosome is taken up in the endosome the exosome 
membrane can fuse to the endosomal membrane. There is also evidence that endocytosis 
of exosomes is receptor mediated, where proteins on the surface of the cell and exosome 
are required for uptake (11). The final theory is specific to phagocytic cells, where it is 
thought that exosomes can be taken up by phagocytosis and then fuse to the phagocytic 
membrane to release their content into the cytoplasm (11).  
Discovery of miRNAs in exosomes 
Within the past decade or so miRNAs have been observed in the extracellular space 
(10). These extracellular miRNAs can be contained within vesicles like exosomes or are 
free-floating, perhaps bound by protein (14). While there is some debate within the field 
about the exact source of extracellular miRNA and which source contributes the most to 
extracellular miRNA content, exosomes have been isolated by various methods and have 
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been found to contain miRNAs that are resistant to RNase treatment (10, 12). Researchers 
were initially interested in extracellular miRNAs for their potential as biomarkers for 
various diseases (15); however, in 2007, Valadi et. al. investigated the ability of exosomal 
miRNAs and mRNA to be functionally transferred between immune cells as a novel way 
cells could exchange information (10).  
 
Selective loading of miRNAs into exosomes 
The composition of miRNAs secreted from a cell within exosomes is different from 
the profile of the parent cell (16–20). This observation led to the hypothesis that miRNAs 
are not merely passively packaged into exosomes, but are selectively loaded into these 
vesicles. There have been a few studies done investigating the mechanism of how miRNAs 
are loaded into exosomes. An approach taken by several groups was to immunoprecipitate 
a biotin tagged miRNA that is normally found within exosomes and a miRNA that is 
normally not found within exosomes. The proteins that associated with the exosomal 
miRNA but not with the nonexosomal miRNA were used as candidates for potential factors 
that could be involved in miRNA loading. In primary human T cells and the Jurkat T cell 
line, hnRNPA2B1 was implicated in sorting (19) while YBX1 was implicated in 293T cells 
(20). Another idea is that the level of the mRNA target could affect the loading of miRNAs 
into exosomes (18) where if more of the miRNA targets are present in a cell, then the 





Intercellular communication via exosomal miRNAs 
Since the initial observation that miRNAs were contained within exosomes and 
could potentially be transferred between cells as a form of intercellular communication, 
many other groups have begun to investigate this idea (21, 22). The bulk of the work 
investigating the functional transfer of miRNAs is focused on cell culture, cancer cells, and 
immune cells (21, 22). In cell culture, for example, cancer cells secrete miR-105, which is 
able to promote metastasis by destroying endothelial barriers (23). In immune cells, 
Monteclavo et. al. demonstrated that miRNAs could be shuttled between dendritic cells 
and mediate target knockdown in recipient cells (12). Additionally, miRNAs can be 
transferred between T cells and DCs at the immune synapse (24). Finally, one of the few 
studies investigating the function of exosomal miRNA communication in vivo focuses on 
the role exosomal miRNA, Let7d,which contributes to the functional repression of Th1 cell 
by Tregs (25). These studies highlight the functional transfer of miRNAs via exosomes as 
a form of intercellular communication.  
While previous studies provide important evidence that miRNAs are transferred 
between immune cells via exosomes, it is still unclear in some cases whether the transfer 
is merely upregulating the endogenous miRNA. Additionally, the physiological relevance 
of the transfer of miRNAs still remains uncertain. The key question of whether 
endogenously produced exosomes and their miRNA cargos are important for cellular 
communication in vivo is just beginning to be addressed. Our studies focus on miR-146a 
and miR-155 which are two important immune miRNAs. These two miRNAs play 
opposing role during inflammation where miR-155 promotes and miR-146a dampens 
inflammatory responses and our work focuses on the role of the transfer of these miRNAs 
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during inflammatory responses as discussed in Chapter 2. 
Dissertation summary 
This dissertation aims to investigate the functional transfer of two immune 
miRNAs, miR-155 and miR-146a, via exosomes and the importance of exosomal 
communication in vivo. Using specific miRNA knockout cells and mice we investigated 
the exogenous delivery of miR-155 and miR-146a and determined that their delivery was 
able to knockdown their respective targets. Additionally, we address whether the delivery 
of these miRNAs alters the cellular response to endotoxin. The importance of exosome 
communication in vivo remains largely unexplored. Therefore, this dissertation focuses in 
the second half on the relevance of exosomes during hematopoietic homeostasis and during 
immune responses using the Rab27DKO mouse model.  
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RAB27-DEPENDENT EXOSOME PRODUCTION INHIBITS CHRONIC 
INFLAMMATION AND ENABLES ACUTE RESPONSES TO  
INFLAMMATORY STIMULI
Abstract 
Extracellular vesicles, including exosomes, have recently been implicated as novel 
mediators of immune cell communication in mammals. However, roles for endogenously 
produced exosomes in regulating immune cell functions in vivo are just beginning to be 
identified. Here, we demonstrate that Rab27a and b double knockout (Rab27DKO) mice 
that are deficient in exosome secretion have a chronic, low-grade inflammatory phenotype 
characterized by elevated inflammatory cytokines, myeloproliferation, and a metabolic 
syndrome. Upon further investigation, we found that some of these phenotypes could be 
complemented by WT hematopoietic cells or administration of exosomes produced by 
GM-CSF expanded bone marrow cells. Additionally, chronically inflamed Rab27DKO 
mice had a blunted response to bacterial LPS, resembling endotoxin tolerance. This defect 
was rescued by bone marrow exosomes from WT but not miR-155-/- cells suggesting that 
uptake of miR-155 containing exosomes is important for proper LPS response. Further, we 
found that SHIP1, a direct target of miR-155 known to promote endotoxin tolerance, was 
elevated in Rab27DKO mice and decreased following treatment with WT but not miR-
155-/- exosomes. Together, our study finds that Rab27-dependent exosome production 
contributes to homeostasis within the hematopoietic system and appropriate 
responsiveness to inflammatory stimuli. 
Introduction 
The mammalian inflammatory response must maintain an intricate balance between 
pro- and anti-inflammatory signals. Proper control of inflammation is needed to clear 
infections as well as maintain commensal microbe populations and overall homeostasis of 
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tissues. When this balance is disrupted, a chronic, low-grade inflammation develops and 
over time can contribute to a variety of diseases associated with aging, including obesity 
and type 2 diabetes (1). Noncoding RNAs are important in regulating this delicate balance 
as demonstrated in mice lacking miR-146a that develop an age-dependent, chronic 
inflammatory disease (2, 3). Chronic inflammation and the metabolic disorders associated 
with it are expanding at an alarming rate putting enormous stress on the U.S. medical 
system and overall economy (4). There is a pressing need to improve our understanding of 
the underlying mechanisms that contribute to chronic inflammation in order to develop 
effective therapies moving forward. 
Proper communication between immune cells is essential for homeostasis and 
appropriate responses to inflammatory cues, including those that drive chronic 
inflammation. Over the past decades, researchers have begun to investigate a novel form 
of intercellular communication between immune cells mediated by small lipid vesicles 
called exosomes (5–8). The transfer of cellular contents including proteins, RNAs, and 
other molecules by exosomes has been reported. Exosome-mediated transfer of 
microRNAs (miRNAs) has become of particular interest in the field (8–10) because 
miRNAs can be transferred between different cell types, including immune cells, to 
regulate cellular responses (3, 7). For instance, miRNAs can be shuttled between dendritic 
cells (DCs) and mediate target knockdown in recipient cells (12) as well as be transferred 
between T cells and DCs at the immunological synapse (13). Further, miRNA transfer via 
exosomes conveys resistance to hepatitis B and contributed to interferon- antiviral 
responses in mice (14). There are also examples of specific miRNAs being transferred 
between immune cells and altering responses. For example, the exogenous delivery of 
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exosomal miR-155 leads to an enhanced response to inflammatory challenge while 
administration of exosomal miR-146a reduces response (11). Such responses have been 
observed both systemically and in specific tissues, including those that make up the central 
nervous system (15). Additionally, miR-155 can also be transferred from acute myeloid 
leukemia (AML) cells to healthy blood cells, resulting in the suppression of c-MYB and 
compromised hematopoiesis in the context of cancer (16). These examples clearly 
demonstrate that miRNAs contained within exosomes are involved in the communication 
between immune and other hematopoietic cells, during both physiological and pathological 
situations. 
Despite the expanding amount of research investigating the functional transfer of 
miRNAs between immune cells, the key question of whether endogenously produced 
exosomes and their miRNA cargos are important for cellular communication in vivo is just 
beginning to be addressed as new tools emerge. Rab27a and b double knockout 
(Rab27DKO) mice provide one such reagent with which to study the roles of exosomes in 
vivo as these mice exhibit significantly reduced exosome release, among other phenotypes 
(17–20). Rab27DKO regulatory T cells (Tregs) have previously been used to study the 
function of an exosomal miRNA, Let7d, in suppression of Th1 cells by Tregs using an 
adoptive transfer model (9). However, it remains unclear whether endogenous exosomes 
play important roles in other immune cell functions, including innate immunity.  
In our current study, we found that Rab27DKO mice have a chronic, low-grade 
inflammatory condition characterized by increased baseline inflammatory cytokines, 
myeloproliferation, and indicators of metabolic disease. Some of these phenotypes were 
cell extrinsic and could be rescued, at least in part, by WT BM cells or injections of isolated 
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WT exosomes from BM cells. This indicates that exosome uptake is important for 
maintenance of hematopoietic homeostasis and prevention of aberrant chronic 
inflammation. Chronically inflamed Rab27DKO mice were also hyporesponsive to 
challenge with LPS, and thus resembled a state of endotoxin tolerance (21). This is also 
reminiscent of what is seen in obese patients who have defects in clearing infections despite 
higher resting inflammatory markers (22). Further, we found that the response of 
Rab27DKO mice to LPS can be rescued by delivery of WT but not miR-155-/- exosomes, 
suggesting that miR-155 contained within exosomes is essential proper responses to 
inflammatory cues. SHIP1, a miR-155 target that negatively regulates inflammatory 
responses (23, 24) and is involved in establishing tolerance to LPS (25), is elevated in 
Rab27DKO mice compared to WT mice. However, SHIP1 levels were reduced following 
administration of WT but not miR-155-/- exosomes in mice challenged with LPS 
implicating miR-155 targeting of SHIP1 in the exosomal rescue of Rab27DKO mouse 
response to LPS. Together, these results provide evidence that exosomal communication 
is important for proper maintenance of homeostasis in the immune system, and subsequent 
responses to challenge with LPS.   
Results 
Rab27DKO mice have a chronic, low-grade inflammatory phenotype 
Upon phenotyping Rab27DKO mice, we observed that granulocyte-monocyte 
(GM) myeloid population, marked by CD11b+ and GR1+, were expanded in the 
Rab27DKO mice in both the spleen and BM compartments with a corresponding decrease 
in the B220+ B cell population compared to WT controls (Figure 4.1a-c, e-g). There were 
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Figure 4.1. Rab27DKO mice display chronic, low-grade inflammation. 6-8 week old 
WT or Rab27DKO mouse hematopoietic populations were analyzed in the bone marrow 
and the spleen. (a) Granulocyte-monocyte myeloid (GR1+ CD11b+), erythroid precursor 
(Ter119+), and B cell (B220+) populations were analyzed in the spleen via flow cytometry. 
Representative flow plots are displayed. (b-d) Relative levels of B220+, Ter119+, and 
GR1+ CD11b+ populations in the spleen were quantified and set relative to WT controls. 
(e) Representative flow plots of myeloid (GR1+ CD11b+), erythroid precursor (Ter119+),
and B cell (B220+) populations in the bone marrow. (f-h) Relative levels of B220+,
Ter119+, and GR1+ CD11b+ populations were quantified in the bone marrow. (I) Spleen
weights of WT and Rab27DKO mice. (j-k) TNF and IL-6 protein levels were quantified
via ELISA from the serum of WT and Rab27DKO mice and set relative to the Rab27DKO
group. (l) Weights of WT and Rab27DKO female mice were tracked from 10 to 14 weeks
of age. (m-n) Body composition of the same mice tracked in L was analyzed by NMR at
week 15. Percent fat and lean composition is shown. (o) Fasting glucose levels were
measured in the same mice tracked in L at week 15. Dots represent individual mice and the
bar represents the mean. Relative levels are relative to the WT condition where the average
of the WT condition is set to 1 unless otherwise noted. Data are representative of at least 3
individual experiments. P values are either stated or *, p < 0.05; **, p < 0.01; ***, p <.001;
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signs of extramedullary hematopoiesis indicated by the expansion of Ter119+ 
erythroid precursor cells in the spleen, and a reduction of these cells in the BM (Figure 
4.1a, d, e, h). Increased spleen weights were also observed in the Rab27DKO vs. WT 
control mice (Figure 4.1i). These data suggest that the Rab27DKO mice have a mild 
myeloproliferative disorder.  
Beyond hematopoietic cell differences, the proinflammatory cytokines IL-6 
and TNF were elevated above baseline in the serum of Rab27DKO mice (Figure 
4.1j-k). Corresponding to this chronic inflammation we noted that female but not male 
Rab27DKO mice gained significantly more weight than their WT counterparts and had 
increased body fat and a decreased lean body composition (Figure 4.1l-n). Additionally, 
Rab27DKO mice had higher fasting glucose levels than their WT counterparts (Figure 
4.1o). These results indicate Rab27DKO mice develop a chronic, low-grade 
inflammatory condition.  
Certain Rab27DKO chronic inflammatory phenotypes are cell extrinsic 
To determine whether these phenotypes are cell intrinsic or extrinsic we 
utilized BM radiation chimeras. CD45.1 WT mice were lethally irradiated and 
reconstituted with either a 1:1 mixture of CD45.1 WT/CD45.2 WT, Rab27DKO 
(CD45.2)/WT (CD45.1), or only Rab27DKO BM cells. After two months, we 
found that CD45.1 and CD45.2 populations were fairly equivalent in both groups 
(Figure 4.2a-b). Rab27DKO BM that was in the presence of WT BM no longer 
had accumulation of Ter119+ erythroid precursor cells in the spleen as seen in the 
Rab27DKO mice (Figure 4.2c-d). Spleen weights were also decreased compared to the
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Figure 4.2. Certain Rab27DKO phenotypes are cell extrinsic. WT mice were lethally 
irradiated and reconstituted with either a 1:1 mix of WT (CD45.1+) and Rab27DKO 
(CD45.2+), Rab27DKO (CD45.2+) alone, or 1:1 mix of CD45.1+ and CD45.2+ WT bone 
marrow for 2 months. (a) Representative flow plots of reconstitution efficiency in the 
spleen using CD45 as a marker. (b) Reconstitution efficacy was quantified by CD45 
markers in the spleen, genotype of CD45 marker is indicated below the graph. (c-e) 
Ter119+ and B220+ representative flow plots are shown for the spleen and relative levels 
are quantified to the right. (f) CD45 markers within the B220+ population in the spleen 
where black is CD45.1 and grey is CD45.2 relative levels. (g-h) GR1 CD11b+ 
representative flow plots and percentages with quantification of relative levels to the right. 
(i) CD45 markers within the GR1+ CD11b+ population. (j) Spleen weight in grams. (k)
Body weight of each group was tracked over time and age of the mice is shown. Mice had
been reconstituted for 6 weeks before weight measurements began. (l) Percent body fat of
each treatment group at 18 weeks of age and 10 weeks post-BM reconstitution as measured
by NMR. (m) Percent lean mass of each treatment group at 18 weeks of age and 10 weeks
post-BM reconstitution as measured by NMR. Dots represent individual mice and the bar
represents the mean. Relative levels are relative to the WT condition where the average of
the WT condition is set to 1. Data are representative of 4 individual experiments. P values
are either stated or *, p < .05; **, p < 0.01; ***, p <.001 Student’s t-test. For body weight
comparison * marks P values of < .05 between the WT and Rab27DKO reconstituted
groups and T marks P values of < .05 between the Rab27DKO and Rab27DKO/WT
reconstituted groups.





































































































































































































































































































































































































































Rab27DKO BM alone group (Figure 4.2j). Additionally, there was some rescue of B220+ 
B and CD11b+ GR1+ GM myeloid cell populations in the spleens of mice reconstituted 
with the WT/Rab27DKO BM mixtures (Figure 4.2d-e, g-h). To investigate 
whether Rab27DKO or WT cells composed these populations, we gated on CD45.1 
and CD45.2 and found that within the B220+ B cell population Rab27DKO nd WT 
cell proportions were equivalent (Figure 4.2f). Within the GR1+ CD11b+ population 
there was a subtle bias towards the CD45.2+ Rab27DKO cells suggesting there could still 
be some cell intrinsic functions for Rab27a/b in this cellular compartment (Figure 4.2i). 
Similar trends were seen in the BM with the exception of the Ter119+ population, 
which was not rescued with the presence of WT BM (data not shown). Further, the 
weight gain and increased body fat seen in the Rab27DKO mice was recapitulated 
by the reconstitution of Rab27DKO BM alone but not the WT/Rab27DKO chimera 
group (Figure 4.2k-m). Of note, this weight gain phenotype was not as drastic as 
that seen in the Rab27DKO mice themselves. This suggests that the weight gain in 
Rab27DKO mice is in part due to the hematopoietic compartment and cell extrinsic 
factors. These results provide evidence that certain Rab27DKO phenotypes are cell 
extrinsic and potentially regulated by exosomes, while others may be intrinsic and 
regulated by exosome independent mechanisms. 
 
Delivery of WT exosomes can complement certain Rab27DKO phenotypes 
Due to our observations that some of the Rab27DKO chronic, low-
grade inflammatory phenotypes are a due to extrinsic mechanisms, we investigated 
whether exosome uptake was an important contributing factor to homeostasis within the  
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immune system. To test this, we intraperitoneally (i.p.) injected Rab27DKO mice with 
exosomes produced by WT GM-CSF cultured bone marrow (GM-BM) cells or the control 
“exosome” pellet from Rab27DKO GM-BM cells which have been previously shown to 
produce significantly fewer exosomes (11, 17). Injections were performed two times per 
week over the course of four weeks. 
Ter119+ erythroid precursor cell expansion in the Rab27DKO spleens was reduced 
following injections of WT exosomes, but not injection of the control Rab27DKO exosome 
pellet (Figure 4.3a-b). The splenic GR1+ CD11b+ GM myeloid population was partially 
rescued by WT exosome injections (Figure 4.3d-e) while the B cell population was not 
(Figure 4.3a and c). Spleen weights were decreased in Rab27DKO mice that received WT 
exosomes (Figure 4.3f), suggesting that the extramedullary hematopoietic phenotype was 
rescued following administration of WT exosomes. The GR1+ CD11b+ GM population in 
the BM recovered after WT exosomes were injected (Figure 4.3j-k); however, the 
Rab27DKO Ter119+ and B220+ BM cellular populations were not altered following 
delivery of WT exosomes (Figure 4.3g-i). Levels of IL-6 in the Rab27DKO serum were 
also reduced to normal levels following injection of WT exosomes (Figure 4.3l). These 
results suggest that some Rab27DKO mouse phenotypes are dependent on GM-BM 
exosome uptake, such as Ter119+ cell accumulation in the spleen and splenomegaly, 
increased GM myeloid cells and elevated cytokine levels, while others are independent of 
GM-BM exosome uptake. This experiment was repeated with PBS injections as a control 
instead of the Rab27DKO exosomal pellet and similar results were observed (data not 
shown).  
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Figure 4.3. WT exosome treatment can complement certain Rab27DKO phenotypes. 
Rab27DKO mice were injected 2 times per week for 4 weeks with WT exosomes or the 
exosomal pellet from Rab27DKO GM-BMs. (a-c) Representative flow plot of Ter119+ 
and B220+ cells in the spleen with quantification of relative levels to the right. Mouse 
genotype and exosome treatment are indicated below the graphs. (d-e) GR1+ CD11b+ 
representative flow plots in the spleen and quantification of these percentages. (f) Spleen 
weights in grams of the treatment groups. (g-i) Representative flow plot of Ter119+ and 
B220+ cells in the bone marrow and relative levels are quantified to the right. (j-k) GR1+ 
CD11b+ representative flow plots in the bone marrow and quantification of these 
percentages. (l) IL-6 levels were quantified via ELISA from the serum. Relative levels are 
relative to the WT condition where the average of the WT condition is set to 1. Data are 
representative of 1 experiment. Dots represent individual mice and the bar represents the 
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Rab27DKO mice are refractory to treatment with LPS 
Due to the increased baseline inflammation in the Rab27DKO mice, we wanted to 
investigate how these mice respond to a LPS challenge. To do this, we i.p. injected WT or 
Rab27DKO mice with a nonlethal dose of LPS and analyzed the inflammatory response 
by isolating serum at 2 and 6h post-LPS injection and performing IL-6 and TNFα ELISAs. 
Despite starting out with increased TNFα and IL-6 basal levels, Rab27DKO mice could 
not raise these levels in response to LPS to the same extent as WT mice (Figure 4.4a-c). 
Normally, during a LPS challenge mice will undergo a switch in hematopoietic 
development in the BM compartment called emergency granulopoiesis, where the GR1+ 
CD11b+ GM myeloid population expands and the B220+ B and Ter119+ erythroid 
precursor cell populations contracts by 72h after LPS stimulation. Rab27DKO mice were 
unable to shift their myeloid, B, and erythroid precursor populations in response to LPS, 
which was observed in their WT counterparts (Figure 4.4d-h). These results indicate that 
Rab27DKO mice are refractory to stimulation with LPS.  
Exosome injection restores the Rab27DKO response to LPS 
To determine if the failure of Rab27DKO mice to respond to LPS was due to a lack 
of exosome uptake, we i.p. injected WT exosomes into Rab27DKO mice, or PBS, 24h 
before LPS injection (Figure 4.5a). Serum levels of TNFα and IL-6 were significantly 
increased when Rab27DKO mice were pre-treated with WT exosomes at 2- or 6-h post-
LPS injection (Figure 4.5b). To analyze changes in emergency granulopoiesis, mice were 
injected a second time with exosomes 48h and harvested 72h post-LPS injection (Figure 
4.5a). Rab27DKO mice given WT exosomes were able to expand their CD11b+ GR1+  
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Figure 4.4. Rab27DKO mice have a refractory response to LPS. WT or Rab27DKO 
mice were challenged with or without LPS. Serum was taken 2 and 6h post-LPS challenge 
while immune populations were examined 72h post-LPS. (a-c) Relative levels of TNFα 
and IL-6 in the serum at 2 and or 6h post-LPS administration with WT LPS treatment group 
set to 1. (d-e) Representative flow plots of myeloid (GR1+ Cd11b+), B cell (B220+) and 
erythroid precursor (Ter119+) populations for each condition in the bone marrow 
compartment. (f-h) Relative levels of B220+, CD11b GR1+, and Ter119+ population are 
shown with the WT +LPS average set to 1. Data are representative of 3 separate 
experiments. Dots represent individual mice and the bar represents the mean. P values are 
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Figure 4.5. Injection of WT exosomes restores responsiveness to LPS by Rab27DKO 
mice. (a) Rab27DKO mice were either i.p injected with a PBS mock control or WT 
exosomes 24h before an LPS challenge. Serum was taken 2 or 6h post-LPS injection for 
ELISAs. 48h after LPS administration exosomes were injected again and 72h post-LPS 
immune populations were analyzed. (b) Relative levels of TNFα at 2h post-LPS and IL-6 
in the serum at 6h post-LPS administration with WT treated with LPS was set to 1. (c-d) 
Representative flow plots of myeloid (GR1+ CD11b+) population in the bone marrow 
compartment with quantification to the right where the LPS treated group was set relative 
to the no LPS group to show the responsiveness of the population. (e-g) Representative 
flow plots for B cell (B220+) and erythroid precursor (Ter119+) populations in the bone 
marrow compartment with quantification to the right where the LPS treated group was set 
relative to the no LPS group to show the responsiveness of the population. Dotted line 
marks no change between LPS and no LPS groups. Data are representative of 2 separate 
experiments. Dots represent individual mice and the bar represents the mean. P values are 
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populations and reduce their B220+ B cell and Ter119+ erythroid precursor populations 
and in response to LPS (Figure 4.5c-g) suggesting that the uptake of WT exosomes is able 
to restore the ability of Rab27DKO mice to perform emergency granulopoiesis in response 
to LPS. It is important to note that the two-injection regiment did not rescue the baseline 
levels of myeloid, B, and erythroid precursor cells, but did rescue the responsiveness of 
these populations to LPS (Figure 4.5c and f). These results demonstrate that uptake of GM-
BM derived exosomes can complement the refractory response to LPS in Rab27DKO mice, 
and suggests that exosomes are involved in proper responsiveness to endotoxin in vivo.  
Exosomal miR-155-dependent rescue of LPS responsiveness 
in Rab27DKO BMDCs  
Based on our findings that Rab27DKO mice have a refractory response to 
endotoxin that involves exosome uptake, we wanted to investigate which factor in the 
exosome could be responsible for this outcome. Based on our previous findings that miR-
155 containing exosomes were able to bolster the response to endotoxin (11), we performed 
the following experiments. Rab27DKO, WT, or miR-155-/- GM-BM derived exosome 
pellets were administered to recipient Rab27DKO BMDCs, followed by LPS 
administration 24h later. Two hours post-LPS treatment, TNF levels were increased in 
the Rab27DKO BMDCs given WT exosomes but not the Rab27DKO BMDCs that 
received their own exosome pellet or miR-155-/- exosomes (Figure 4.6a) indicating that 
WT exosomes can rescue this defect through a miR-155-dependent mechanism. We next 
investigated whether SHIP1, a target of miR-155 that negatively regulates inflammation 
and responses to LPS, was affected by the administration of WT exosomes. We found that 
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Figure 4.6. Restoration of LPS responsiveness by Rab27DKO mice is dependent on 
miR-155.  
(A) Rab27DKO BMDCs were treated with Rab27DKO exosomal pellet, WT exosomes, or
miR-155-/- exosomes from GM-BMs 24h before LPS administration. Relative media
TNFα levels 2h post-LPS administration are shown with the WT group treated with LPS
was set as 1. n = 7. (B) Rab27DKO BMDCs were treated with the Rab27DKO, WT, or
miR-155-/- exosomal pellet from GM-BMs 24h before LPS administration. 6h after LPS
treatment RNA was harvested and SHIP1 levels were assayed with qRT-PCR with L32 as
a loading control. Data are set relative to the Rab27DKO BMDC treated with WT
exosomes which is set to 1. n = 5 (C) Representative western blot of SHIP1 in Rab27DKO
BMDCs that have been given WT, Rab27DKO, or miR-155-/- exosome pellets from GM-
BMs and then treated with LPS. (D) Rab27DKO mice were either i.p injected with a
Rab27DKO, WT, or miR-155-/- exosome pellets 24h before an LPS challenge. Serum was
taken 2 post-LPS injection for ELISAs. Values are set relative to Rab27DKO +Rab27DKO
exosome LPS treatment which is set to 1. (E-F) Levels of SHIP1 mRNA in resting WT and
Rab27DKO mice in the spleen and bone marrow relative to L32 loading control. (G)
Westerns of SHIP1 in the spleen and bone marrow with GAPDH as a loading control. (H)
Levels of SHIP1 mRNA in Rab27DKO mice BM that received Rab27DKO, WT, or miR-
155-/- exosomal pellets then were treated with LPS for 72h. (I) Representative flow plots
of the myeloid (GR1+ CD11b+) population for each condition in the bone marrow
compartment from the same experiment set up in H. (J) Ratio of the CD11b GR1+
population is shown of the LPS treatment group compared to the no LPS treatment group.
Dotted line marks no change between LPS and no LPS treatments. Data is representative
of at least 2 separate experiments. The error bars represent +/- S.E. Dots represent
individual mice and the bar represents the mean. P values are either stated or *, p < 0.05;
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WT but not miR-155-/- exosomes were able to reduce SHIP1 levels in Rab27DKO 
BMDCs, corresponding to increased TNF levels (Figure 4.6b-c), consistent with previous 
reports of SHIP1 negatively regulating TNF production (27). These results indicate that 
exosomal miR-155 is required for exosome rescue of Rab27DKO BMDC responses to LPS 
through a mechanism involving repression of SHIP1. 
Rescue of Rab27DKO mouse responses to LPS is dependent on 
miR-155-containing exosomes 
Based on our in vitro observations, we investigated the requirement of miR-155 in 
exosomes for the rescue of Rab27DKO mouse responses to LPS. To study this, we injected 
WT, miR-155-/- or Rab27DKO GM-BM derived exosome pellets into Rab27DKO mice 
24h before LPS injection and again 48h after LPS injection with the same timeline as 
Figure 4.5a. Rab27DKO mice treated with WT exosomes had enhanced TNFα production 
by 2h post-LPS challenge, that was restored back to WT levels, while TNFα levels in LPS 
treated Rab27DKO mice given miR-155-/- or Rab27DKO exosome pellets were not 
rescued (Figure 4.6d). We also found that resting Rab27DKO mice had increased levels of 
SHIP1 (Figure 4.6e-g), suggesting that the Rab27DKO mice are trying to compensate for 
their chronic inflammatory status by upregulating a negative regulator of inflammation. 
This increase in SHIP1 in resting conditions could explain why the Rab27DKO mice are 
hyporesponsive to LPS, and why WT exosome administration aids in the rescue of 
Rab27DKO response to LPS through a miR-155-dependent mechanism. This hypothesis 
is supported by the observed reduction in SHIP1 levels when LPS-treated Rab27DKO mice 
received WT but not miR-155-/- exosomes (Figure 4.6h). Additionally, the GM myeloid 
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population was increased in response to LPS administration following pretreatment with 
WT but not miR-155-/- exosomes (Figure 4.6i-j). These results provide evidence that miR-
155 is required for exosomes to rescue LPS responsiveness by Rab27DKO mice, and that 
reductions in the miR-155 target SHIP1 are mediating this rescue.  
Discussion 
While it is clear from the literature that exosomes are important for intercellular 
communication between immune cells (7, 28), the roles of endogenously produced 
exosomes in vivo are just beginning to be investigated. Previous studies have shown that 
endogenous exosome production and content are affected by disease states in humans (29, 
30) and can be used as biomarkers. However, it is unclear from these studies whether 
exosomes are playing a role in disease or if they are mere byproducts. Additionally, 
manipulated tumor exosomes can activate CD8+ T cells in vivo (31), and endogenous 
exosomes can mediate Treg suppression of Th1 cells via Let7d in an adoptive transfer 
system (32). While these studies provide evidence for the importance of endogenously 
produced exosomes during immunity, we designed our approach utilizing the Rab27DKO 
mouse model. Because these mice have defective exosome production (17, 32) we were 
able to study endogenous exosome production with minimal manipulation.
It is important to note that the Rab27DKO mouse model has defects beyond 
exosome release. Rab27a and/or b deficient mice have been shown to have defective 
granule release by platelets, cytotoxic T cells and neutrophils as well as improper 
neutrophil chemotaxis in certain contexts (18–20, 33). There may also be a role for the 
Rab27DKO proteins in recycling of membrane proteins and phagosome function (34,35). 
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Based on these additional functions of the Rab27 proteins in immune and cellular 
functions it is critical to distinguish these other functions from their role in 
exosome secretion. To address this, we attempted to rescue observed phenotypes with 
either WT hematopoietic cells or the administration of WT exosomes. If the defect was 
rescued by both approaches, then it suggests that a lack of exosome uptake contributes to 
the phenotype. Our data demonstrate that exosome uptake is essential 
for hematopoietic homeostasis and the prevention of chronic inflammation.  
Corresponding to increased basal inflammation and obesity, the Rab27DKO mice 
were hyporesponsive to LPS, consistent with previous findings that Rab27a 
knockout mice (ashen) are protected from LPS sepsis (36). Of clinical relevance, 
this effect is also observed in obese patients that have higher levels of resting 
proinflammatory cytokines but have defective responses to immunological 
challenges (22). We hypothesize that the Rab27DKO mice are less responsive 
to LPS because they have increased negative regulators of inflammation, such as 
SHIP1 (25, 27), as a way to combat their chronic inflammatory condition. This 
would explain why WT exosomes could rescue Rab27DKO response to LPS while 
miR-155-/- exosomes could not as SHIP1 is a known miR-155 target (24). Our model 
for how exosome uptake is affecting the LPS response is summarized in Figure 
4.7. Together our findings implicate endogenously produced miRNA containing 
exosomes in the regulation of an innate immune response in vivo. 
Although our findings indicate that exosomal communication is needed 
to maintain hematopoietic homeostasis, it remains to be clarified which component of 
the exosome contributes  to  these  physiological  effects.  Previous  studies  highlight  the
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Figure 4.7. Model of the role of exosomal miR-155 in the LPS response. In a WT 
scenario, miR-155 can be transferred to a recipient cell leading to the knockdown of targets 
like SHIP1. Then the cell receives an LPS signal and can properly respond properly. 
However, in the Rab27DKO model, cells are defective in producing the appropriate 
amounts of exosomes, therefore the recipient cells do not receive miR-155 and cannot 
downregulate targets such as SHIP1, and thus respond improperly to LPS. In the last case, 
the cells are making exosomes but they do not contain miR-155 resulting in the lack of 



















































importance of certain contents of exosomes for immune cell responses (7, 28). Exosomes 
can directly present antigen via MHC II molecules on their surface to T cells (37, 38). 
Activation of NK cells can be mediated by NKG2D ligands and IL-15R on DC exosomes 
(39). Further, mRNAs and miRNAs can be transferred between cells via exosomes mediate 
immune response (8, 12, 32). These examples and more summarized in Théry et al. and 
Robbins et al. (7, 28) show that there are many potential molecules contained on or within 
exosomes that could be contributing to baseline phenotypes observed in the Rab27DKO 
mice.  
Our experiments provide strong evidence that the transfer of exosomes containing 
miR-155 is important for proper responsiveness to LPS. However, while our experiments 
strongly suggest that miR-155 itself is involved in this, it is important to note that other 
exosomal factors could be altered by the deletion of miR-155 in exosome donor cells. One 
example of how the lack of miR-155 might affect exosomal communication is the recent 
report that deletion of miR-155 in a cell line alters exosome synthesis (40). Despite these 
possibilities, our data strongly support the hypothesis that exosomes are critical for limiting 
chronic inflammation and the range of phenotypes involved in this condition as well as for 
enabling proper responses to inflammatory cues through a miR-155 dependent mechanism. 
In order to further understand the role of endogenously produced exosomes in 
immune cell communication novel reagents are required moving forward. The 
development of another way to specifically decrease exosome production in vivo would be 
helpful to see if the phenotypes observed in a different model of defective exosome 
production mimics the phenotypes seen in Rab27DKO mice. To specifically delve into the 
role of miRNAs within exosomes a reagent where the production of miRNA-containing 
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exosomes can be specifically blocked in vivo is also needed. As we begin to identify factors 
involved in miRNA loading, such as Ybx1 (41), novel mouse strains can be created to 
address these questions. Furthermore, the production of exosomes containing only the 
miRNA of interest would make a strong tool both for further understanding of that miRNA 
within exosomes and for therapeutic applications down the road. 
The increased inflammation and weight gain observed in female Rab27DKO mice 
indicates that exosomes are key regulators of chronic inflammation, and present a valuable 
model to better understand the role of exosomes in this condition. Chronic inflammation 
and associated metabolic diseases pose an enormous economic and medical burden making 
it essential to understand the underlying mechanisms of these disorders. Due to our 
observations that exosome delivery could rescue chronic inflammation and responsiveness 
to LPS, we propose that exosomes could potentially be used in a therapeutic manner to 
promote these outcomes clinically. Additionally, the differential response of WT versus 
miR-155-/- exosome treatment suggests that miRNAs can impact the function of the 
exosomes and their ability to alter response to LPS. Therefore, it stands to reason that the 
miRNA contents of exosomes could be manipulated to alter the therapeutic outcome 
desired from exosome treatment. 
Materials and methods 
Mice 
CD45.2 WT (Jackson Labs), CD45.1 WT (Jackson Labs), and Rab27DKO (Rab27a 
ash/ash Rab27b−/−) mice (Tanya Tolmachova and Miguel C. Seabra, Imperial College 
London) are on a C57BL6 genetic background and housed in the animal facility at the 
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University of Utah. Experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Utah. Mice were age matched and sex matched, and were 
in the age range of 8–16 weeks old for all experiments.  
Exosome isolation and procedures 
Differential centrifugation was performed to isolate exosomes from BM 
conditioned medium. Initial spins consisted of a 10 min spin at 1,000g, a 2,000g spin for 
10 min and a 10,000g spin for 30 min. The supernatant was retained each time. The 
supernatant was then spun at 100,000g for 70 min and the pellet was resuspended in 25ml 
1 × PBS, to dilute remaining soluble factors, followed by another centrifugation at 
100,000g for 70 min. The final pellet contained the exosomes, which were resuspended in 
PBS. This protocol is based on a previous exosome isolation methods (42). We used a 
Thermo Scientific Sorvall Lynx 6000 with a T26-8 × 50 rotor. For the in vitro and in vivo
experiments, exosomes were isolated from BM cultured in GM-CSF (GM-BM cells), 
where BM cells were incubated for 3 days with 20ng/ul GM-CSF and then given an 
additional 5ml of medium with 20ng/ul GM-CSF for a total of 7 days of culture. For the in
vitro experiments, exosomes isolated from 3 million GM-BM cells were transferred to the 
same amount of recipient cells. For the in vivo experiments, each mouse was i.p injected 
with exosome pellets resuspended in 100 ul of 1x PBS. These exosomes were derived from 
3x10cm plates of 3 million GM-BMs per plate and resuspended in 100ul PBS, which yields 
approximately 109 exosomes as previously quantified (11). Protein concentrations in the 
exosome preparations were also quantified and similar protein levels were injected. 
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Flow cytometry 
Fluorophore-conjugated antibodies against the indicated surface markers 
(eBioscience) were used to stain RBC-depleted splenocytes and BM cells. Stained cells 
were analyzed with a BD LSR Fortessa flow cytometer, and further data analysis was 
carried out with FlowJo software. 
ELISA 
The enzyme-linked immunosorbent assay (ELISA) used to quantify mouse IL-6 
and TNFα concentrations were obtained from eBioscience and were performed using the 
manufacturer’s suggested protocol.  
Immunoblotting 
Cellular extract was size fractionated via SDS-PAGE and immunoblotting was 
performed in accordance with standard protocols. Specific antibodies were used to detect 
SHIP1 (Santa Cruz sc-1964) and GAPDH (Abcam ab9485). 
RNA isolation and qRT–PCR 
RNA isolation was performed using the miRNeasy kit (Qiagen), according to 
manufacturer’s instructions. cDNA from total RNA was made with qScript using 90ng of 
RNA from each sample (Quanta). qPCR was performed with Promega GoTaq pPCR 
master mix. L32 levels were used to normalize mRNA expression levels. Primer sequences 




L32-F (5′-AGCTCCCAAAAATAGACGCAC-3′) and 
L32-R (5′-TTCATAGCAGTAGGCACAAAGG-3′).  
BM reconstitution 
Mice were lethally irradiated (1,000 rads) using an X-ray source (Rad Source 
RS200 biological system). Following irradiation, mice were injected with three million BM 
cells via retro-orbital injection and aged for 2 months before analysis. 
In vivo LPS administration to mice 
Escherichia coli LPS (Sigma) was administered through i.p. injections at a 
sublethal concentration of 50μg. In exosome injection experiments, exosomes were i.p. 
injected 24h before LPS injection and again at 48h post-LPS injection. Mice were 
harvested at 72h post-LPS injection. 
Mouse body composition and glucose testing 
The composition of fat and lean tissue was determined with the NMR Bruker 
Minispec. Fasting glucose levels were determined by fasting the mice for 6h and then using 
FreeStyle Lite Test Strips and a Bayer Contour Blood Glucose Meter (Amazon). 
Statistics 
Data were analyzed using Student’s t-tests with Graphpad Prism or Excel. P-values 
were either listed or represented by the following number of asterisks: * p <0.05; ** p 
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<0.01; *** p <0.001; **** p <0.0001. 
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CHAPTER 5 
IMPORTANCE OF EXOSOME RELEASE IN T-CELL ACTIVATION 
AND AUTOIMMUNITY DRIVEN BY T-CELLS 
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Abstract 
T-cell activation is essential for proper adaptive immune responses. While there are
many known signaling pathways involved in this activation, a novel form of intercellular 
communication between immune cells has been uncovered. Exosomes are small lipid 
packages that contain protein, mRNA and miRNAs and have been implicated in 
intercellular communication. However, the role of exosomes in T-cell activation has yet to 
be investigated. Utilizing the Rab27DKO mouse model, which has significantly decreased 
production of exosomes, we investigated the role of exosomes in T-cell activation. We 
initially observed that Rab27DKO mice have significantly increased activated T-cells in 
resting conditions. This increase of activated T-cells could not be rescued by the presence 
of WT bone marrow in a bone marrow chimera model. Additionally, the injection of 
BMDC derived exosomes could not rescue this phenotype. These data suggest that the 
aberrant activation of T-cells is a cell intrinsic phenotype that is not dependent on uptake 
of WT exosomes. When Rab27DKO mice were challenged with Experimental 
autoimmune encephalomyelitis (EAE), a mouse model of MS, the Rab27DKO mice got 
significantly worsened disease phenotypes compared to their WT counterparts. This 
suggests that the increase of activated T-cell in the resting mice results in worsened disease 
outcome. It remains unclear whether lack of exosome release or some other intrinsic 
functions of Rab27a and b are driving this phenotype. 
Introduction 
During an adaptive immune response, naïve T-cells become activated in order to 
perform their functions. This activation is classically thought to involve key signaling 
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molecules such as CD3 and CD28 as well as TCR MHC interactions. Recently researchers 
have identified a novel form of intercellular communication where immune cells can 
transfer content to each other using small lipid vesicles called exosomes (1–3). The 
biogenesis of exosomes begins with the invagination of the limiting membrane of the 
endosome which forms the multivesicular body (MVB). Exosomes are release into the 
extracellular space when the MVB is traffic to and fuses to the plasma membrane (4–7). 
By knocking out Rab27a and b the MVB cannot be retained at the plasma membrane and 
thus the secretion of exosomes is diminished (8–11). This provides a model that can be 
used to investigate the role of exosomes in immune cell function and development. For 
example, Rab27DKO mice have been used to investigate the role of exosomes in Treg 
suppression of Th1 cells (12).  
Using the Rab27DKO mice, we investigated whether the release or uptake of 
exosomes could be involved in T-cell activation. We first profiled their T-cell activation 
status at baseline conditions and observed that Rab27DKO mice had significantly more 
activated T-cells than their WT counterparts.  The aberrant activation of Rab27DKO T-
cells appeared to be a cell intrinsic phenotype as the presence of WT bone marrow in a 
bone marrow chimera did not rescue this defect. Additionally, the injection of WT 
exosomes into Rab27DKO mice did not rescue this defect suggesting that either exosome 
release or another cell intrinsic role of Rab27a or b resulted in the aberrant T-cell activation 
in these mice. In a model of multiple sclerosis (MS), experimental autoimmune 
encephalomyelitis (EAE), Rab27DKO had significantly worsened disease. This suggested 
that the increase of activated T-cells at resting conditions led to a worse outcome in an 
autoimmune disease mediated by T-cells in the Rab27DKO mice. 
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Results 
Rab27DKO mice have increased activated T-cells 
In order to investigate the role of exosome release in T-cell homeostasis we utilized 
the Rab27DKO mouse model, which is defective in exosome release. We analyzed T-cell 
populations via flow cytometry in Rab27DKO and WT mice. Overall CD4+ and CD8+ T-
cell populations were not different between the groups; however, when we investigated the 
activation status of these cells we noted that Rab27DKO mice had significantly increased 
activated T-cells as indicated by an increase in CD62L- CD44+ cells, CD62L- CD69+ 
cells, CD69 mean fluorescence intensity (MFI) and the overall decrease in CD62L MFI 
(Figure 5.1a-d). Additionally, 6 month old Rab27DKO mice have increased t follicular 
helper cells (TFH), marked by PD1 and ICOS, and germinal center B cells (GCB) B220+ 
IgD low cells that are GL7+ FAS+ (Figure 5.1e-g). These results suggest that Rab27a and 
b are required for preventing aberrant activation of T-cells and germinal centers which may 
be due to the inability of these cell either to release or receive exosomes from other cells.  
Activated T-cell phenotype in Rab27DKO mice is cell intrinsic 
Based on our observation that T-cell activation was increased in Rab27DKO mice, 
we wanted to investigate whether this was due to a cell intrinsic defect, such as the inability 
to release exosomes, or a cell extrinsic defect, such as the inability to take up exosomes. In 
order to investigate this, we made bone marrow chimera mice. CD45.1 WT mice were 
lethally irradiated and reconstituted with either a CD45.1/CD45.2 WT chimera, a 
Rab27DKO (CD45.2+)/CD45.1 chimera, or Rab27DKO bone marrow alone. 
After 2 months, the bone marrow and spleens from these mice were isolated and 
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Figure 5.1. Rab27DKO mice have increased activated T-cells, TFH cells and germinal 
center B cells. Spleens from 6-8-week old WT and Rab27DKO mice were analyzed for 
the T-cell activation status. TFH and GCB populations were analyzed in 6-month old mice. 
(A) CD69+ CD62L- and CD44+ CD62L- cells were analyzed in the CD3+ CD4+ T-cell
population and representative flow plots are displayed. (B) Relative levels of CD62L- 
CD69+ and CD62L- CD44+ T-cells are displays with WT average set as 1. (C)
Representative MFI plots of CD62L and CD69 within the CD3+ CD4+ population. (D)
Relative MFI of CD62L and CD69 with WT average set as 1. (E) Representative flow plot
of ICOS+ PD1+ (TFH) cells in the CD3+ CD4+ gate from 6-month-old mice. (F)
Percentages of ICOS+ PD1+ (TFH) cells in the CD3+ CD4+ population are shown.
Percentages of Fas+ GL7+ (GCB) cells in the B220+ IgDlo population are shown. (G)
Representative flow plots of FAS+ GL7+ cells in the B220+ IgDlo gate are shown. Data
are representative of 2 separate experiments. Dots represent individual mice and the bar




hematopoietic populations were analyzed via flow cytometry. BM reconstitution was 
effective as shown by CD45.1 and CD45.2 composition in the spleen (Figure 5.2d).  
The presence of WT bone marrow was not able to rescue activated T-cell 
phenotypes, as indicated by increased CD62L- CD69+ cells, CD69 MFI and decreased 
CD62L MFI in mice that were reconstituted with Rab27DKO bone marrow alone as well 
as the mice that reconstituted with a mix of Rab27DKO and WT bone marrow (Figure 
5.2a-c). Additionally, the CD62L- CD69+ cells were composed of cells derived from 
Rab27DKO bone marrow as shown by their CD45 markers (Figure 5.2 e-f). These data 
suggest that the activation of resting Rab27DKO T-cells is cell intrinsic and not due to the 
uptake of exosomes or from defects in the functions of other cell types such as regulatory 
T-cells.
Exosome injection does not rescue T-cell activation phenotype 
in Rab27DKO mice 
In order to determine that exosome uptake is indeed not contributing to the activated 
T-cell phenotype in the Rab27DKO mice we performed BMDC derived exosome
injections of resting Rab27DKO mice. Rab27DKO mice were injected 2 times a week for 
4 weeks with WT exosomes while controls received PBS injections. After 4 weeks, spleens 
were isolated and T-cell activation status was determined via flow cytometry. Injection of 
BMDC derived exosomes did not alleviate T-cell activation phenotypes (Figure 5.3). These 
data suggest that BMDC derived exosomes cannot rescue Rab27DKO T-cell over-
activation.  
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Figure 5.2. Aberrant activation of Rab27DKO CD4+ T-cells is a cell intrinsic defect. 
Bone marrow chimera experiments were performed to determine whether T-cell activation 
in Rab27DKO mice was a cell intrinsic or extrinsic defect with the following groups; WT 
(CD45.1)/ WT (CD45.2) bone marrow mixed, Rab27DKO (CD45.2)/ WT (CD45.1) 
mixed, and Rab27DKO bone marrow alone. (A) CD69+ CD62L- and CD44+ CD62L- cells 
were analyzed in the CD3+ CD4+ T-cell population and representative flow plots are 
displayed. (B-C) Relative levels of CD62L- CD69+ and CD62L- CD44+ T-cells are 
displays with WT average set as 1. (D) Reconstitution efficiency in the spleen as measured 
by CD45 composition (E) Relative CD45.1 or CD45.2 in the CD62L- CD69+ population. 
The CD45 marker genotype is marked below the graph. (F) Relative CD45.1 or CD45.2 in 
the CD62L- CD44+ population. Data is representative of 3 separate experiments. Dots 
represent individual mice and the bar represents the mean. **, p < 0.01; ***, p <.001; ****, 
p <.0001 Student’s t-test. 
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Figure 5.3. WT exosome injections cannot rescue aberrant T-cell activation in 
Rab27DKO mice. WT or Rab27DKO exosomes were injected into Rab27DKO 2 times a 
week for 4 weeks and then spleens were harvested to analyze T-cell activation status. (A) 
CD69+ CD62L- and CD44+ CD62L- cells were analyzed in the CD3+ CD4+ T-cell 
population and representative flow plots are displayed. (B-C) Relative levels of CD62L- 
CD69+ and CD62L- CD44+ T-cells are displays with WT average set as 1. Data are 
representative of 2 separate experiments. Dots represent individual mice and the bar 
represents the mean. **, p < 0.01; ***, p <.001; Student’s t-test. 
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Rab27DKO mice show increased EAE disease 
Due to the increase of resting activated T-cells in Rab27DKO mice we decided to  
challenge these mice with a disease model that is T-cell-dependent, EAE. Rab27DKO mice 
developed worsened EAE disease scores compared to WT mice (Figure 5.4a). 
Additionally, Th1 and Th17 cells were increased in the brains of the Rab27DKO mice 
given EAE (Figure 5.4b-d). These results suggest that the T-cells are indeed more activated 
in Rab27DKO mice as they are associated with increase disease. 
Discussion 
While much is known about the signaling events that contribute to T-cell activation, 
the exact mechanism of this activation remains unclear. Here, we propose a role for 
exosome release in this activation. While more work is needed confirm the exosome release 
is indeed the driving factor in our model, we do have evidence supporting this hypothesis. 
We found that Rab27DKO mice have increased activated T-cells at resting 
conditions compared to WT mice. These results suggest that the Rab27 proteins are playing 
a role in repressing aberrant T-cell activation; however, it does not reveal whether this 
phenotype is due to exosomes or not. Our first way of addressing this was to determine if 
the increased activation of T-cells in the Rab27DKO mice was a cell intrinsic or extrinsic 
defect. We observed that the presence of WT bone marrow could not rescue this defect 
suggesting that something inherent to the Rab27DKO T-cells was resulting in their 
activation. To confirm that the uptake of exosomes was not affecting the activation of T-
cells, we injected WT exosomes into Rab27DKO mice and observed that this did not rescue 
the activation defect. All these data suggest that either decreased exosome release is  
82 
Figure 5.4. Rab27DKO mice are more susceptible to EAE. WT or Rab27DKO mice 
were given EAE and their disease scores were tracked over time. At day 18 mice were 
sacrificed and their brains were analyzed for Th1 and Th17 T-cell subsets. (A) IL-17+ or 
IFNy+ cells were analyzed in the CD3+ CD4+ T-cell population and representative flow 
plots from the brain are displayed. (B-C) Total cell numbers of Th17 cells (IL-17+) and 
Th1 (IFNy+) T-cells in the brain are displayed. Data are representative of 2 separate 
experiments. Dots represent individual mice and the bar represents the mean. *, p >.05; 
***, p <.001 Student’s t-test. 
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contributing to the T-cell activation or that Rab27 a and/or b are contributing to this 
activation independent of exosome release.  
The implications of aberrantly activated T-cells are strong for autoimmunity. For 
this reason, we challenged our Rab27DKO mice with a model of MS, EAE. Rab27DKO 
mice have significantly worsened disease score compared to their WT counterparts. This 
suggests that the prevalence of activated T-cells in the Rab27DKO mice is predisposing 
them for worsened disease outcomes.  
When interpreting our results, it is important to note the Rab27DKO mice have 
defects outside of exosome release. Rab27a and/or b have been shown to have defective 
granules release in immune cells such as cytotoxic T-cells as well as defective neutrophil 
chemotaxis (13–19). There may also be a role for the Rab27 proteins in the recycling of 
membrane proteins and phagosome function (20, 21). Based on these additional roles of 
the Rab27 proteins in other immune and cellular functions it is important to tease apart 
these other roles from their role on exosome secretion. Our approach to this was to attempt 
to rescue observed phenotypes with the addition of WT exosomes. If the defect is rescued, 
then that suggests that the lack of uptake of exosomal content is contributing to the defect. 
In the case of aberrant T-cell activation, the addition of WT exosome was unable to rescue 
the defects we observed. This suggests that the Rab27 proteins could be playing a role 
outside of exosomes that is having the observed effect, or that the release of exosome is 
the contributing factor to this phenotype.   
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Materials and methods 
Mice 
Wt (Jackson Labs) and CD45.1 Wt (Jackson Labs) Rab27 DKO (Rab27a ash/ash 
Rab27b−/−) mice (Tanya Tolmachova and Miguel C. Seabra, Imperial College London) 
are on a C57BL6 genetic background and housed in the animal facility at the University of 
Utah. Experiments were approved by the Institutional Animal Care and Use Committee at 
the University of Utah. Mice were age matched and sex matched, and were in the age range 
of 8–16 weeks old.  
Exosome isolation and procedures 
Differential centrifugation was performed to isolate exosomes from conditioned 
medium. Initial spins consisted of a 10-min spin at 1,000g, a 2,000g spin for 10 min and a 
10,000g spin for 30 min. The supernatant was retained each time. The supernatant was then 
spun at 100,000g for 70 min and the pellet was resuspended in 1 × PBS, to dilute remaining 
soluble factors, followed by another centrifugation at 100,000g for 70 min. The final pellet 
contained the exosomes, which were resuspended in tissue culture media. We used a 
Thermo Scientific Sorvall Lynx 6000 with a T26-8 × 50 rotor. For the in vivo experiments 
exosomes were isolated from GM-SCF treated bone marrow where bone marrow cells were 
incubated for 3 days with 20ng/ul GM-CSF and then spiked with 5ml media and 20ng/ul 
GM-CSF for a total of 7 day of culture. For the in vivo experiments, one mouse receives 
exosomes derived from 3 10cm plates of 3 million GM-BMs, which yields approximately 
10^9 exosomes as previously quantified (22). Protein concentrations are quantified and 
similar protein levels are injected except for Rab27DKO exosomal pellets. 
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Flow cytometry 
Fluorophore-conjugated antibodies against the indicated surface markers were used 
to stain RBC-depleted splenocytes and BM. Stained cells were analyzed with a BD LSR 
Fortessa flow cytometer, and data analysis was carried out with FlowJo software. 
EAE 
For induction of EAE, mice were injected subcutaneously into the base of the tail 
with a volume of 200 µl containing 100 µg/ml MOG35-55 peptide (TOCRIS) emulsified in 
complete Freund's adjuvant (CFA). Mice were also i.p. injected with 200 ng of pertussis 
toxin on days 0 and 2, and clinical symptoms were scored regularly according to the 
following criteria: 0, no symptoms; 0.5, partially limp tail; 1, completely limp tail; 1.5, 
impaired righting reflex; 2, hind limb paresis; 2.5, hind-limb paralysis; 3, forelimb 
weakness; 4, complete paralysis; 5, death. 
BM reconstitution 
Mice were lethally irradiated (1,000 rads) was delivered using an X-ray source. 
Following irradiation, mice were injected with three million BM cells via retro-orbital 
injection and aged for 2 months. 
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Existing state of the exosomal miRNA communication field 
Since the discovery that exosomes contain miRNAs, there has been significant 
progress made in understanding the roles of exosomal miRNAs during intercellular 
communication. Many different cell types can secrete miRNA containing exosomes and 
there is evidence that the miRNAs can be functionally transferred between cells (1–5). 
However, many of these studies do not use a miRNA knockout as a recipient of the 
miRNA containing exosomes, which would demonstrate that the miRNA is not 
endogenously upregulated but is delivered exogenously. There are additionally many 
examples of the functionality of transferred miRNAs in cancer and immune cells (1, 2, 5–
8). For example, exosomes can transfer miRNAs between T cells and dendritic cells in a 
unidirectional manner to modulate gene expression in the recipient cells (1). 
Additionally, miRNAs are functionally transferred between mouse dendritic cells (9). In 
the case of cancer cells, exosomal miRNAs prime brain metastasis by inducing the loss of 
PTEN (10).  
While these studies and many more have contributed much to what we know 
about the functional transfer of miRNAs via exosomes there still remain key questions 
that need to be addressed. One of these questions concerns the selective loading of 
miRNAs into exosomes during their biogenesis. Several proteins have been implicated in 
this loading in different cell types including hnRNPA2B1, YBX1, and SNYCRIP (11–
13). However, it still remains to be determined whether these proteins play this role in 
many cell types or if there’s a cell-specific sorting mechanism. It seems likely that there 
is a common mechanism across all cell types, but this remains to be elucidated.  
Another major question remaining in the field concerns how recipient cells take 
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up the miRNA containing exosomes and how the miRNA is delivered to the cytoplasm. 
There is evidence of several different mechanisms of miRNA delivery by exosomes; 
including endocytosis, plasma membrane fusion, and phagocytosis (14–18). Integrins 
play an important role in the adherence of the exosome membrane to the membrane of 
the recipient cell (18, 19). It is unknown whether exosome uptake is receptor mediated, 
although there is some evidence for this (20), the specific receptors remain unclear. 
Tetraspanins have been implicated in receptor mediated uptake, but more work is needed 
to determine whether these proteins play a role in cell specific uptake of exosomes (18, 
21, 22). Treatment of cells or exosomes with trypsin results in significantly reduced 
uptake of exosomal miRNAs, suggesting that proteins on both the cell and exosomes are 
needed for uptake (data not shown). Further, we have performed studies with inhibitors 
of cytoskeletal rearrangement and found that rearrangement is necessary for exosome 
uptake (data not shown).  
Another outstanding question in the field is whether the transfer of miRNAs via 
exosomes is an important event during normal biological events. In order to properly 
address this question, a model where exosome secretion is defective is needed. The 
model that has begun to emerge to address this question is the Rab27DKO mouse model, 
which has been characterized as having decreased exosome production (23, 24). While 
there are caveats with this model, it remains the best model in the field to study the role 
of exosomes in vivo. There has been one major study investigating the role of exosome in 
regulatory T cell function with this model but many questions remain about the role of 
exosomes during normal hematopoietic development and during response to challenge  
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New insights into the roles of exosomal transfer 
of miRNAs and the roles of exosomes during  
intercellular communication in vivo 
In our studies, we have observed that miRNAs miR-155 and miR-146a can be 
functionally transferred between immune cells and alter how those cells respond to a 
challenge. In the case of miR-155, we have observed that exosomes can transfer this 
miRNA to recipient cells resulting in the knockdown of normal miR-155 targets in a seed 
dependent manner and increasing the inflammatory response to endotoxin. The transfer 
of miR-146a in exosomes also knocks down its targets in a seed dependent manner but 
decreases the inflammatory response to endotoxin. These results support the idea that the 
transfer of miRNAs via exosomes can be used to communicate inflammatory status. 
Using the Rab27DKO mouse model, we have begun to investigate the role of 
exosomes during in vivo processes. We have evidence that suggests that exosomes may 
be playing important roles in baseline hematopoietic homeostasis, chronic inflammation, 
and response to bacterial challenge. Some of these phenotypes seem to be dependent on 
exosome uptake as the administration of exosomes rescues some baseline hematopoietic 
homeostasis defects and rescues the response to endotoxin in the Rab27DKO mice. Other 
phenotypes seem to be cell intrinsic as the presence of WT bone marrow and the injection 
of exosomes does not rescue the T cell activation phenotype in Rab27DKO mice. This 
could mean that either the release of exosomes is needed to prevent aberrant T cell 
activation or that there is some other role of Rab27a and or b that is resulting in the 
increased activation of T cells. All of these results strongly suggest that exosomes are 
playing important roles in vivo. Additionally, in the case of endotoxin response, the 
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presence of miR-155 in exosomes is essential for the rescue of the defective endotoxin 
response in the Rab27DKO mice. This result suggests that this particular miRNA is a 
major factor involved in endotoxin response in vivo.  
Future directions in the exosomal communication field 
Despite all we have learned from our studies, there is still much work to be done 
to characterize the role of exosomes during development and immune responses as well 
as the role of transferred miRNAs in intercellular communication. One aspect in the field 
that needs to be standardized is how we determine whether a particular miRNA is 
functionally transferred via exosomes. In order to determine whether there is a 
physiological role for transferred miRNAs there are several key experiments that must be 
done. miRNA knockout cells should be used as recipients to assure that the increase in 
miRNA signal is due to exogenous delivery and not endogenous upregulation. 
Additionally, to determine if the delivery of the miRNA is directly targeting the 3’UTR 
of it’s targets, luciferase assays can be performed where a WT and seed mutant version of 
a target 3’UTR is used. In order to address whether the differences seen between WT and 
miRNA knockout exosomes is due to other changes in the content of the exosomes apart 
for the lack of the factor of interest, mimic experiments can be performed using miRNA 
knockout exosomes loaded with a mimic of the miRNA of interest and transferring the 
mimic loaded exosomes to recipient miRNA knockout cells compared to ones that did 
not contain mimic. Finally, in order to determine if the transfer of the miRNA of interest 
is important in vivo, Rab27DKO mice can be used to assess whether exosome 
communication is important in certain scenarios and whether your favorite miRNA 
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contained within exosomes is sufficient to rescue defects in Rab27DKO mice. These 
experiments are essential when trying to determine the functionality of a particular 
miRNA being transferred.  
In order for the field of miRNA exosome communication to move forward 
essential tools are required. An important new tool would be a mouse model that is 
unable to load miRNAs into exosomes. This model would separate the miRNA function 
in the exosomes from other exosome functions. While there has been some progress on 
elucidating what proteins might be involved in the loading of miRNA into exosomes, it 
remains to be seen if there is a common mechanism of loading in all cell types.    
The role of exosomal communication in vivo is just beginning to be investigated. 
The Rab27DKO model provides a mouse model where the secretion of exosomes is 
decrease; however, this model has many caveats. The largest drawback to this model is 
that Rab27 a and b have other functions in the cell besides exosome release. Due to the 
other roles of Rab27 a and b, it cannot be assumed that phenotypes observed in the 
Rab27DKO mice are due to exosomal communication. One way to address this issue and 
specifically look at the role of exosome uptake is with exosome injection experiments. If 
the injection of exosomes rescues a phenotype in the Rab27DKO mice, then that supports 
the conclusion that exosome uptake is contributing to that phenotype. 
The implications of the use of miRNAs contained within exosomes as a tool for 
communication are vast. Classically, cells are thought to utilize proteins as a way to 
signal each other of their status; however, now a new molecule, exosomally contained 
miRNAs, have been implicated in this signaling. Not only does the transfer of miRNAs 
represent a novel form of intercellular communication but also it presents a potential new 
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and better way to deliver therapeutics. 
Implications of the exosome mediated transfer of miRNAs 
With the deeper understanding of exosome and exosomal communication via 
miRNAs, we can begin to utilize this knowledge in potential therapeutic applications. 
Due to our observations that exosome delivery could rescue chronic inflammation and 
responsiveness to LPS, we propose that exosomes could potentially be used in a 
therapeutic manner to promote these outcomes clinically. Additionally, the differential 
response of WT versus miR-155-/- exosome treatment suggests that miRNAs can impact 
the function of the exosomes and their ability to alter response to LPS. Therefore, it 
stands to reason that the miRNA contents of exosomes could be manipulated to alter the 
therapeutic outcome desired from exosome treatment. For example, in the case where an 
increase in inflammatory response is desired, such as a vaccine adjuvant, miR-155 
containing exosomes could be administered. In the case where a decreased response is 
desired, such as during sepsis, treatment with miR-146a exosomes could be used. 
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